No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antineoplastic Agents, Immunological / adverse effects*
-
Drug-Related Side Effects and Adverse Reactions / diagnosis
-
Drug-Related Side Effects and Adverse Reactions / etiology
-
Drug-Related Side Effects and Adverse Reactions / immunology
-
Drug-Related Side Effects and Adverse Reactions / therapy*
-
Follow-Up Studies
-
Humans
-
Ipilimumab / adverse effects
-
Medical Oncology / standards*
-
Neoplasms / drug therapy
-
Neoplasms / immunology
-
Nivolumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Ipilimumab
-
Nivolumab
-
pembrolizumab